Eledon Pharmaceuticals (ELDN) Payables (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Payables of $6.6 million for Q1 2026, up 126.99% year-on-year from $2.9 million in Q1 2025, and up 81.56% on a QoQ basis from $3.6 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Payables data on file, last reported at $6.6 million in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 126.99% year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.6 million (up 126.99% YoY), and the FY2025 full-year result was $3.6 million, down 37.82% from the prior year.
- Payables for Q1 2026 stood at $6.6 million, up from $3.6 million in the prior quarter.
- Across five years, Payables topped out at $6.6 million in Q1 2026 and bottomed at $465000.0 in Q3 2023.
- The 5-year median for Payables is $2.9 million (2023), against an average of $3.2 million.
- The widest annual swing landed in 2023, when Payables sank 87.95%; it then surged 1160.22% in 2024.
- A 5-year view of Payables shows it stood at $2.2 million in 2022, then plunged by 56.05% to $967000.0 in 2023, then soared by 503.21% to $5.8 million in 2024, then tumbled by 37.82% to $3.6 million in 2025, then jumped by 81.56% to $6.6 million in 2026.
- The last three Payables figures came in at $6.6 million (Q1 2026), $3.6 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 6.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.59 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 967,000.00 |
| Sep 30, 2023 | 465,000.00 |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.81 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 857,000.00 |
| Mar 31, 2021 | 1.51 Mn |
| Dec 31, 2020 | 1.37 Mn |
| Sep 30, 2020 | 758,000.00 |
| Jun 30, 2020 | 150,000.00 |
| Mar 31, 2020 | 741,000.00 |
| Dec 31, 2019 | 329,000.00 |
| Sep 30, 2019 | 256,000.00 |
| Jun 30, 2019 | 753,000.00 |
| Mar 31, 2019 | 480,000.00 |
| Dec 31, 2018 | 689,000.00 |
| Sep 30, 2018 | 751,000.00 |
| Jun 30, 2018 | 706,000.00 |
| Mar 31, 2018 | 449,000.00 |
| Dec 31, 2017 | 418,000.00 |
| Sep 30, 2017 | 189,000.00 |
| Jun 30, 2017 | 374,000.00 |
| Mar 31, 2017 | 276,000.00 |
| Dec 31, 2016 | 3.79 Mn |
| Sep 30, 2016 | 886,000.00 |
| Jun 30, 2016 | 1.85 Mn |
| Mar 31, 2016 | 1.89 Mn |
| Dec 31, 2015 | 1.21 Mn |
| Sep 30, 2015 | 1.65 Mn |
| Jun 30, 2015 | 1.70 Mn |
| Mar 31, 2015 | 3.43 Mn |
| Dec 31, 2014 | 765,000.00 |
| Sep 30, 2014 | 2.89 Mn |
| Dec 31, 2013 | 5,000.00 |